peace
the pxs4782a deal will be a company changer for pxs imo. pxs has the drug already to go in human trials. take pill once a day orally. how easy is that. i cant believe how cheap company is at 11 cents especially with all these deals being made around the world regarding NASH with big pharmaceutical company's. trading at cash backing at 11 cents its a joke imo.
Pharmaxis CEO Gary Phillips said, “The extensive pre‐clinical program performed on PXS4728A has confirmed that it has all characteristics of a successful once a day, oral drug. It has shown excellent efficacy in several in vivo inflammation models including liver diseases such as NASH and the findings will soon be presented at a scientific conference. In regulatory toxicity studies, PXS4728A has been well tolerated and shown a very good safety profile.”
Recent reports suggest that approximately 13 million people in the US and Europe may have NASH and
advanced fibrosis with the market estimated to be worth in excess of $35 billion. Although there are no existing approved drugs to treat NASH, the disease is attracting considerable research interest with Genfit (PPARagonist), Intercept (FXR activator) and Gilead (LOXL2 antibody) all due to report on large proof of conceptstudies in coming months.
frosty
Gilead in $470 million NASH deal, page-3
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.3¢ |
Change
-0.001(2.27%) |
Mkt cap ! $59.04M | |||
| Open | High | Low | Value | Volume |
| 4.4¢ | 4.4¢ | 4.2¢ | $39.11K | 895.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 752779 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.58pm 04/10/2024 (20 minute delay) ? |
| SNT (ASX) Chart |